155 related articles for article (PubMed ID: 37614053)
1. Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.
Cho EJ; Kim MH; Kim YH; Chang K; Choi DJ; Kang WC; Shin J; Kim SH; Lee N; Son JW; Doh JH; Kim WS; Hong SJ; Rhee MY; Ahn Y; Lim SW; Hong SP; Choi SY; Hyon MS; Hwang JY; Kwon K; Cha KS; Ihm SH; Lee JH; Yoo BS; Kim HS
J Clin Hypertens (Greenwich); 2023 Sep; 25(9):817-827. PubMed ID: 37614053
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.
Sung KC; Sung JH; Cho EJ; Ahn JC; Han SH; Kim W; Kim KH; Sohn IS; Shin J; Kim SY; Kim KI; Kang SM; Park SJ; Kim YJ; Shin JH; Park SM; Park CG
J Clin Hypertens (Greenwich); 2022 Oct; 24(10):1298-1309. PubMed ID: 36094783
[TBL] [Abstract][Full Text] [Related]
3. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
[TBL] [Abstract][Full Text] [Related]
4. Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Sarkar G; Gaikwad VB; Sharma A; Halder SK; Kumar DA; Anand J; Agrawal S; Kumbhar A; Kinholkar B; Mathur R; Doshi M; Bachani D; Mehta S
Adv Ther; 2022 Feb; 39(2):923-942. PubMed ID: 34918194
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
Sung KC; Oh YS; Cha DH; Hong SJ; Won KH; Yoo KD; Rha SW; Ahn YK; Ahn JC; Jang JY; Hong TJ; Cho SK; Park SH; Hyon MS; Nam CW; Chae IH; Yoo BS; Song JM; Jeong JO; Yoon YW; Kim BS; Yang TH; Cho DK; Kim SH; Choi YJ; Ahn JH; Jeon DW; Kim HS
Clin Ther; 2018 Jan; 40(1):50-63.e3. PubMed ID: 29248384
[TBL] [Abstract][Full Text] [Related]
6. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.
Hong SJ; Jeong HS; Cho JM; Chang K; Pyun WB; Ahn Y; Hyon MS; Kang WC; Lee JH; Kim HS
Clin Ther; 2019 Feb; 41(2):233-248.e9. PubMed ID: 30665829
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study.
Park CG; Ahn TH; Cho EJ; Kim W; Kim HS; Yang JY; Ryu JG; Kim CH; Hyeon MS; Tak SJ; Im SJ; Ha JW; Pyeon WB; Jae JG; Han GR; Doh JH; Im SW; Lee MM
Clin Ther; 2016 Oct; 38(10):2185-2194. PubMed ID: 27720505
[TBL] [Abstract][Full Text] [Related]
9. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Volpe M; Christian Rump L; Ammentorp B; Laeis P
Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
Hong SJ; Jeong HS; Han SH; Chang KY; Hong BK; Lee BK; Chae SC; Kim WS; Park CG; Heo JH; Lee SU; Kim YD; Kim KS; Choi JH; Kang HJ; Kim JJ; Kang SM; Choi YJ; Shin JH; Chun KJ; Shin DG; Park SH; Kwan J; Choi YJ; Jeong MH; Chae JK; Kim DW; Cho JR; Han KR; Won KH; Park SH; Lee SK; Kim SH; Jung J; Kim CH
Clin Ther; 2017 Oct; 39(10):2049-2060. PubMed ID: 28939406
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
Kim TS; Rha SW; Kim SY; Park DG; Sung KC; Yoon MH; Kim KH; Lee HC; Kim WS; Kim YJ; Ahn JC; Rhee MY; Cha DH; Yoo BS; Park SH; Yoo KD; Jeon DW; Yoon YW; Cho SK; Oh YS
Clin Ther; 2019 Apr; 41(4):728-741. PubMed ID: 30904178
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
15. Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial.
Gnanenthiran SR; Wang N; Di Tanna GL; Salam A; Webster R; de Silva HA; Guggilla R; Jan S; Maulik PK; Naik N; Selak V; Thom S; Prabhakaran D; Schutte AE; Patel A; Rodgers A;
JAMA Cardiol; 2022 Jun; 7(6):645-650. PubMed ID: 35416909
[TBL] [Abstract][Full Text] [Related]
16. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
Calhoun DA; Crikelair NA; Yen J; Glazer RD
Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension.
Grimm RH; Black H; Rowen R; Lewin A; Shi H; Ghadanfar M;
Am J Hypertens; 2002 Jan; 15(1 Pt 1):31-6. PubMed ID: 11824857
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study.
Hong SJ; Sung KC; Lim SW; Kim SY; Kim W; Shin J; Park S; Kim HY; Rhee MY;
Drug Des Devel Ther; 2020; 14():5735-5746. PubMed ID: 33408462
[TBL] [Abstract][Full Text] [Related]
20. Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial.
Wang N; Salam A; Webster R; de Silva A; Guggilla R; Stepien S; Mysore J; Billot L; Jan S; Maulik PK; Naik N; Selak V; Thom S; Prabhakaran D; Patel A; Rodgers A;
JAMA Cardiol; 2020 Nov; 5(11):1219-1226. PubMed ID: 32717045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
